Charles Schwab’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
450,296
+11,018
| +3% | +$286K | ﹤0.01% | 1934 |
|
|
2025
Q1 | $10.8M | Buy |
439,278
+11,518
| +3% | +$282K | ﹤0.01% | 1919 |
|
|
2024
Q4 | $12.3M | Buy |
427,760
+48,096
| +13% | +$1.38M | ﹤0.01% | 1923 |
|
|
2024
Q3 | $14.3M | Buy |
379,664
+202,262
| +114% | +$7.63M | ﹤0.01% | 1867 |
|
|
2024
Q2 | $5.6M | Buy |
177,402
+8,050
| +5% | +$254K | ﹤0.01% | 2309 |
|
|
2024
Q1 | $7.43M | Buy |
+169,352
| New | +$7.43M | ﹤0.01% | 2133 |
|